RXD:NYE-ProShares UltraShort Health Care (USD)

ETF | Trading--Inverse Equity |

Last Closing

USD 11.6148

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-03 )

Largest Industry Peers for Trading--Inverse Equity

ETFs Containing RXD

RLD:CA 0.00 % 0.61 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.40% 53% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.40% 53% F 45% F
Trailing 12 Months  
Capital Gain 2.29% 89% A- 54% F
Dividend Return 2.57% 58% F 48% F
Total Return 4.87% 91% A- 50% F
Trailing 5 Years  
Capital Gain -60.32% 80% B- 6% D-
Dividend Return 2.99% 75% C 6% D-
Total Return -57.33% 80% B- 6% D-
Average Annual (5 Year Horizon)  
Capital Gain 66.86% 39% F 96% N/A
Dividend Return 68.32% 39% F 96% N/A
Total Return 1.47% 60% D- 35% F
Risk Return Profile  
Volatility (Standard Deviation) 432.96% 63% D 3% F
Risk Adjusted Return 15.78% 52% F 34% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.